A Smoking Cessation Intervention for Severe Mental Ill Health Trial (SCIMITAR)

ISRCTN ISRCTN79497236
DOI https://doi.org/10.1186/ISRCTN79497236
Protocol serial number HTA 07/41/05
Sponsor University of York (UK)
Funder Health Technology Assessment Programme
Submission date
29/06/2009
Registration date
03/07/2009
Last edited
14/09/2015
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Simon Gilbody
Scientific

Area 4, Seebohm Rowntree Building
Department of Health Sciences
University of York
Heslington
York
YO10 5DD
United Kingdom

Phone +44 (0)1904 321370
Email sg519@york.ac.uk

Study information

Primary study designInterventional
Study designPilot study and definitive fully randomised controlled trial
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific titleA Smoking Cessation Intervention for Severe Mental Ill Health Trial: a pilot study and definitive randomised evaluation of a bespoke smoking cessation service
Study acronymSCIMITAR
Study objectives1. Bespoke smoking cessation service for people with severe mental ill health is more acceptable than usual GP care
2. Bespoke smoking cessation service for people with mental ill health is more clinically effective than usual GP care in facilitating smoking cessation
3. Bespoke smoking cessation service for people with mental ill health is more cost effective than usual GP care in facilitating smoking cessation
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedTobacco addiction in severe mental illness
InterventionActive intervention: mental health nurse trained in smoking cessation counselling will work in conjunction with the patient and patients' GP or mental health specialist to provide a smoking cessation service individually tailored to each patient with mental ill health. This service will be in line with current National Institute for Clinical Excellence (NICE) guidelines for smoking cessation services and will include group support sessions for patients with mental ill health, pharmacotherapies to aid smoking cessation in addition to regular follow up by the smoking cessation officer.

Control intervention: GP or mental health specialist following current NICE guidelines for smoking cessation services. This may include pharmacotherapies to aid smoking cessation, access to self-help materials and referral to local NHS stop smoking clinics.

The total duration for the treatment and follow-up combined will be 12 months post-recruitment. This applies for both active and control intervention arms of the trial.
Intervention typeBehavioural
Primary outcome measure(s)

Smoking cessation measured at 12 months post-recruitment (validated using carbon monoxide measurements).

Key secondary outcome measure(s)

1. Self reported smoking cessation at 4, 6 and 12 months
2. Health related quality of life (36-item short form health survey [SF-36])
3. Health-state utility (EQ5D) at 4, 6 and 12 months

Completion date31/12/2012

Eligibility

Participant type(s)Patient
Age groupAdult
SexAll
Target sample size at registration100
Key inclusion criteriaAdults of all ages (either sex) with severe and enduring mental illness who currently smoke.
Key exclusion criteria1. Patients with alcohol dependence
2. Patients with co-morbid drug addiction
Date of first enrolment01/06/2010
Date of final enrolment31/12/2012

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

University of York
York
YO10 5DD
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summary
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/03/2015 Yes No
Results article results 01/05/2015 Yes No
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes